Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
FDA approves donanemab, now Kisunla, to treat early Alzheimer's
https://alzheimersnewstoday.com/news/donanemab-approved-early-symptomatic-alzheimers-now-kisunla/
links
backlinks
Tagged with:
fda approval
donanemab
Eli Lilly's donanemab, now Kisunla, was approved by the U.S. Food and Drug Administration for patients with early symptomatic Alzheimer’s.
Roast topics
Find topics
Find it!
